SEC Form 4/A · accession 0001127602-16-055323
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Christopher Causey
Director
Period of report
Jun 2, 2016
Accepted (ET)
Jun 10, 2016 · 4:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jun 2, 2016 | M | 1,250 | $51.77 | A | 2,355 | D | |
| Common StockF2 | Jun 2, 2016 | D | 1,250 | $121.03 | D | 1,105 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Tracking AwardF2 | $51.77 | Jun 2, 2016 | M | 1,250 | D | Jun 28, 2011 | Jun 28, 2020 | Common Stock | 1,250 | 10,000 | D |
Explanation of responses
- F1Exercise of a cash-settled share tracking award pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
- F2This transaction was originally reported on Form 4 filed on June 3, 2016. Due to a clerical error, the original form incorrectly indicated that the number of share tracking awards exercised was 750. The actual number of share tracking awards exercised was 1,250